Election Day not only ushered in marijuana legalization wins in five states, it also brought more than two dozen victories at the city and county levels in California, opening the door to new local markets for cannabis businesses up and down the state.
Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
Pure Extracts is now trading under the symbol "PULL".
A study of 27 people found that psilocybin therapy was more effective than traditional antidepressant medications, “producing large, rapid, and sustained antidepressant effects in patients with major depressive disorder.”
The “pressure will be on” to legalize marijuana in New York and lawmakers will approve it “this year” to offset economic losses from the coronavirus pandemic, Gov. Andrew Cuomo (D) said on Thursday.
Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
The narrow loss of 2016 has been erased.
South Dakota voters have approved two ballot initiatives to legalize marijuana for recreational and medical purposes, according to projections from the Associated Press.
Montana voters have approved a pair of marijuana legalization initiatives, according to a projection by the Associated Press.
Oregon has legalized the medicinal use of psilocybin. Here is why that's big news for the psychedelic drug industry.
Voters in Oregon made history on Tuesday with the passage of two landmark initiatives aimed at reversing the tide of the War on Drugs.
Voters in New Jersey have approved the state’s adult-use cannabis legalization ballot question with overwhelming support, making it the 12th state to end cannabis prohibition.
Four more Ohio cities have adopted local measures to decriminalize marijuana.
Voters in South Dakota made history on Nov. 3, helping the state become the first in the union to pass a constitutional amendment legalizing adult-use cannabis sales without first having an established medical program.
On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
